- Second Largest in the world
- Revenues (2009 - 10) = Rs 137 Crores ($3 billion)
| Rank | Company | Revenue 2010(Rs crore) | Revenue 2010(Rs billion) |
|---|---|---|---|
| 1 | Cipla | 4,198.96 | 41.989 |
| 2 | Ranbaxy (Taken over by Daiichi Sankyo in 2008) | 4,162.25 | 41.622 |
| 3 | Dr. Reddy's Laboratories | 3,763.72 | 37.637 |
| 4 | Sun Pharmaceutical | 2,463.59 | 24.635 |
| 5 | Lupin Ltd | 2,215.52 | 22.155 |
| 6 | Aurobindo Pharma | 2,081.19 | 20.801 |
| 7 | GlaxoSmithKline(British company) | 1,773.41 | 17.734 |
| 8 | Cadila Healthcare | 1,613 | 16.13 |
| 9 | Aventis Pharma(Swedish company)) | 983.80 | 9.838 |
| 10 | Ipca Laboratories | 980.44 | 9.8044 |
- 2% share in global markets, growing at 10% annually
- August 28, 2006, Pennsylvania, US-based Mylan Inc bought Hyderabad-based Matrix Laboratories for $736 million.
- April 20, 2008, Singapore’s Fresenius Kabi bought Dabur Pharma, on June 11, 2008, Japanese innovator medicines company Daiichi Sankyo bought Ranbaxy Laboratories.
- July 27, 2009, French multinational Sanofi Aventis bought Shantha Biotech, on December 16, 2009, US-based Hospira bought the injectables business of Orchid Chemicals.
No comments:
Post a Comment